Metabolic syndrome is a risk factor for colorectal adenoma and cancer: a study in a White population using the harmonized criteria.
Angelo MilanoMaria Antonia BiancoLuigi BuriLivio CipollettaEnzo GrossiGianluca RotondanoFrancesco TessariKonstantinos EfthymakisMatteo NeriPublished in: Therapeutic advances in gastroenterology (2019)
MetS is risk factor for cancer and adenoma in Whites, especially when younger than 50 years. MetS patients might be considered as a high-risk population also in colorectal cancer screening programs.
Keyphrases
- papillary thyroid
- metabolic syndrome
- end stage renal disease
- colorectal cancer screening
- squamous cell
- newly diagnosed
- ejection fraction
- chronic kidney disease
- public health
- prognostic factors
- lymph node metastasis
- squamous cell carcinoma
- insulin resistance
- type diabetes
- childhood cancer
- adipose tissue
- young adults